Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Quarterly results
CC transcript

INCYTE CORP (INCY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 SC 13D/A INCYTE CORP reports a 6.9% stake in Merus n.v.
08/01/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
06/30/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/30/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/08/2023 SC 13G/A BlackRock Inc. reports a 10.5% stake in INCYTE CORPORATION
06/07/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/08/2023 8-K Other Events  Interactive Data
05/02/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/15/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 16.4% stake in Incyte Corporation
02/14/2023 SC 13G/A DODGE & COX reports a 8.7% stake in INCYTE CORPORATION
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.7% stake in Incyte Corp.
02/08/2023 SC 13G/A INCYTE CORP reports a 0% stake in Calithera Biosciences, Inc.
02/07/2023 10-K Annual Report for the period ended December 31, 2022
02/07/2023 8-K Quarterly results
Docs: "Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs"
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/01/2022 8-K Quarterly results
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/02/2022 8-K Quarterly results
Docs: "Conference Call and Webcast Scheduled Today at 8:00 a.m. EDT"
06/16/2022 8-K Quarterly results
05/03/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/03/2022 8-K Quarterly results
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/10/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 16.5% stake in Incyte Corporation
02/14/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 15.9% stake in Incyte Corporation
02/14/2022 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 3.2% stake in INCYTE CORP
02/14/2022 SC 13G DODGE & COX reports a 7.5% stake in INCYTE CORPORATION
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy